We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Grassley Increases Drugmaker Oversight Through False Claims Act
Grassley Increases Drugmaker Oversight Through False Claims Act
February 10, 2006
A key lawmaker has increased government oversight of drugmakers’ dealings with the Medicaid program through an expansion of the False Claims Act (FCA).